Weil Advised Advent International on Acquisition of Sundia
Weil advised Advent International in connection with the acquisition of Sundia MediTech Company, Ltd. (Sundia), a leading contract research and manufacturing organization in China. The transaction is a bolt-on acquisition to BioDuro, in which Weil also advised Advent International in January 2019. Following this transaction, BioDuro will combine with Sundia (hereafter operating as BioDuro-Sundia) and become one of the largest contract research, development and manufacturing organizations with major operations in China and the United States.
The Weil team was led by Private Equity partner Charles Ching and included associates Kenny Yu, Kevin Wang, Benjamin Yao and Carol Jia, and legal consultant Wenyuan Zhao; Tax partner Noah Beck and counsel Gary Silber; Antitrust partner Douglas Nave and counsel Neil Rigby; and International Arbitration & Trade partner Ted Posner.
For further information on the transaction, please click here.
More from the Private Equity Blog
Copyright © 2025 Weil, Gotshal & Manges LLP, All Rights Reserved. The contents of this website may contain attorney advertising under the laws of various states. Prior results do not guarantee a similar outcome. Weil, Gotshal & Manges LLP is headquartered in New York and has office locations in Boston, Brussels, Dallas, Frankfurt, Hong Kong, Houston, London, Los Angeles, Miami, Munich, New York, Paris, San Francisco, Silicon Valley and Washington, D.C.